These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 32301829)

  • 1. Induction of Meal-related Symptoms as a Novel Mechanism of Action of the Duodenal-Jejunal Bypass Sleeve.
    McMaster JJ; Rich GG; Shanahan ER; Do AT; Fletcher LM; Kutyla MJ; Tallis C; Jones MP; Talley NJ; Macdonald GA; Chachay VS; Holtmann GJ
    J Clin Gastroenterol; 2020 Jul; 54(6):528-535. PubMed ID: 32301829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery.
    Tarnoff M; Rodriguez L; Escalona A; Ramos A; Neto M; Alamo M; Reyes E; Pimentel F; Ibanez L
    Surg Endosc; 2009 Mar; 23(3):650-6. PubMed ID: 19067075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.
    Rodriguez-Grunert L; Galvao Neto MP; Alamo M; Ramos AC; Baez PB; Tarnoff M
    Surg Obes Relat Dis; 2008; 4(1):55-9. PubMed ID: 18201671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Management of Anchor Erosion Adjacent to the Pylorus Following Duodenal-Jejunal Bypass Sleeve.
    De Moura EGH; de Moura DTH; Galvão-Neto M; Sakai CM; Silva GLR; Bazarbashi AN; Thompson CC
    Obes Surg; 2019 Jun; 29(6):2003-2004. PubMed ID: 30972635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity.
    Escalona A; Yáñez R; Pimentel F; Galvao M; Ramos AC; Turiel D; Boza C; Awruch D; Gersin K; Ibáñez L
    Surg Obes Relat Dis; 2010 Mar; 6(2):126-31. PubMed ID: 20359665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
    Forner PM; Ramacciotti T; Farey JE; Lord RV
    Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
    Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K
    Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients.
    de Moura EG; Lopes GS; Martins BC; Orso IR; Coutinho AM; de Oliveira SL; Sakai P; Galvão-Neto Mdos P; Santo MA; Sapienza MT; Cecconello I; Buchpiguel CA
    Obes Surg; 2015 Sep; 25(9):1618-25. PubMed ID: 25691349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve in a porcine model: a potentially novel treatment for obesity and type 2 diabetes.
    Tarnoff M; Shikora S; Lembo A
    Surg Endosc; 2008 Mar; 22(3):772-6. PubMed ID: 18270770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion.
    Lee WJ; Almulaifi AM; Tsou JJ; Ser KH; Lee YC; Chen SC
    Surg Obes Relat Dis; 2015; 11(4):765-70. PubMed ID: 25813754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relief of diabetes by duodenal-jejunal bypass sleeve implantation in the high-fat diet and streptozotocin-induced diabetic rat model is associated with an increase in GLP-1 levels and the number of GLP-1-positive cells.
    Shuang J; Zhang Y; Ma L; Tan X; Huang J; Wang X; Xiong G; Jiang Z; Zhang X; DU S; Gu Y; Shi X; Fan Z
    Exp Ther Med; 2015 Oct; 10(4):1355-1363. PubMed ID: 26622491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity.
    Gersin KS; Keller JE; Stefanidis D; Simms CS; Abraham DD; Deal SE; Kuwada TS; Heniford BT
    Surg Innov; 2007 Dec; 14(4):275-8. PubMed ID: 18178916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m
    Boonchaya-Anant P; Bueter M; Gubler C; Gerber PA
    Clin Obes; 2023 Feb; 13(1):e12561. PubMed ID: 36239531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis.
    Rohde U; Hedbäck N; Gluud LL; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2016 Mar; 18(3):300-5. PubMed ID: 26537317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial.
    Risstad H; Søvik TT; Engström M; Aasheim ET; Fagerland MW; Olsén MF; Kristinsson JA; le Roux CW; Bøhmer T; Birkeland KI; Mala T; Olbers T
    JAMA Surg; 2015 Apr; 150(4):352-61. PubMed ID: 25650964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
    Jirapinyo P; Haas AV; Thompson CC
    Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
    Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
    Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
    Patel SR; Hakim D; Mason J; Hakim N
    Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.